Kura Oncology Analyst Ratings
Kura Oncology Analyst Ratings
Kura Oncology Analyst Ratings
Buy Rating Affirmed for Kura Oncology Amidst Promising Ziftomenib Trials and Strategic Advantages
Kura Oncology Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Tourmaline Bio (TRML)
Kura Oncology Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Relay Therapeutics (RLAY), Kura Oncology (KURA)
Kura Oncology Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)
Kura Oncology Analyst Ratings
Scotiabank Keeps Their Hold Rating on Kura Oncology (KURA)
Barclays Remains a Buy on Kura Oncology (KURA)
Buy Rating Affirmed for Kura Oncology Amid Strong Financials and Promising Clinical Milestones
Kura Oncology Analyst Ratings
Kura Oncology Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Kura Oncology, Maintains $32 Price Target
Buy Rating Affirmed: Kura Oncology's KO-2806 Shows Promising Clinical and Market Potential
Buy Rating for Kura Oncology Amid Strong Q4 Results and Promising Ziftomenib Trials
Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), UniQure (QURE)
No Data